RxDoctor Payments Data

Jaclyn Dimattei, NP

Adult Health · Central Islip, NYNPI 1093238222

Payments from drug & device makers

$467in general payments, 2019–2025

Across 21 payments — averaging $22.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amarin Pharma, Inc.$102
  • Otsuka America Pharmaceutical, Inc.$48
  • Avanir Pharmaceuticals, Inc.$47
  • Baxter Healthcare$37
  • Teva Pharmaceuticals USA, Inc.$36
  • Axsome Therapeutics, Inc.$35
  • plus $162 from 8 others

What the payments were for

  • Food & beverage$467100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$467 in reported general payments places this provider in the 55th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$736
Medicare patients
51
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VascepaIcosapent Ethyl391$135,072
OzempicSemaglutide65$69,518
JanuviaSitagliptin Phosphate93$53,488
Icosapent Ethyl197$36,000
JardianceEmpagliflozin32$23,560
MounjaroTirzepatide14$16,940
LinzessLinaclotide25$13,286
FarxigaDapagliflozin Propanediol15$9,675
Levothyroxine Sodium931$8,349
Epinephrine21$7,412
Atorvastatin Calcium814$6,685
Lactulose144$5,357
Alendronate Sodium322$5,296
Omeprazole491$4,382
Advair HfaFluticasone Propion/Salmeterol12$3,812

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$19$53,48893 claims
Lilly USA, LLCMounjaro$23$16,94014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,828 adult health providers in New York.

Other adult health in Central Islip

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →